Jacobs Levy Equity Management Inc. Has $6.33 Million Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Jacobs Levy Equity Management Inc. raised its position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 56.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 301,173 shares of the company's stock after purchasing an additional 108,918 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.74% of Phibro Animal Health worth $6,325,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Graham Capital Management L.P. bought a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $245,000. Deutsche Bank AG boosted its holdings in shares of Phibro Animal Health by 90.8% in the fourth quarter. Deutsche Bank AG now owns 16,873 shares of the company's stock valued at $354,000 after acquiring an additional 8,032 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $1,119,000. CastleKnight Management LP boosted its holdings in shares of Phibro Animal Health by 6.2% in the fourth quarter. CastleKnight Management LP now owns 389,433 shares of the company's stock valued at $8,178,000 after acquiring an additional 22,796 shares in the last quarter. Finally, Cetera Investment Advisers bought a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $204,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Stock Performance

Shares of NASDAQ PAHC traded up $0.17 during mid-day trading on Friday, hitting $24.00. The company had a trading volume of 306,154 shares, compared to its average volume of 196,805. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55. The firm has a market cap of $972.82 million, a P/E ratio of 50.00, a PEG ratio of 0.45 and a beta of 0.62. The business's 50-day simple moving average is $20.08 and its 200-day simple moving average is $21.88. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The business had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. As a group, analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is currently 61.54%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Barclays lifted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. StockNews.com upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $20.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.